**8.1 Conjunctivitis**

Oral erythromycin base or ethylsuccinate is a usual treatment for conjunctivitis in the infant, although erythromycin has been reported as risk factor for infantile hypertrophic pyloric stenosis when administered the first 2 weeks of life. Thus, parents and physicians should observe infants closely for any signs of intestinal obstruction. Azithromycin is an acceptable alternative [30, 33, 35] which is also recommended by WHO in neonates with chlamydial conjunctivitis [46]. Dosages in the most preferable treatments are:

